Nano HoldingsNano Holdings, Inc.4571東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP
It lost about ¥554 for every ¥100 of sales at the operating level. Revenue changed +60.8% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | — | —× | -26.4% | —× | — |
| 2023 | — | —× | -22.7% | —× | — |
| 2024 | — | —× | -14.4% | —× | — |
| 2025 | — | —× | -18.4% | —× | — |
| 2026 | — | —× | -19.1% | —× | — |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 264 | 202 | 136 | 109 | 174 |
| Cost of revenue | 41 | 43 | 25 | 30 | 21 |
| Gross profit | 223 | 160 | 111 | 78 | 153 |
| SG&A | 2,284 | 1,406 | 975 | 834 | 1,119 |
| Operating income | -2,061 | -1,246 | -864 | -755 | -966 |
| Pretax income | -1,879 | -1,308 | -778 | -833 | -941 |
| Income tax | 3 | 2 | 2 | 3 | 3 |
| Net income attributable to owners | -1,882 | -1,311 | -780 | -835 | -944 |
| Operating margin | -780.6% | -616.3% | -637.9% | -696.1% | -553.6% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥1.1B | ¥1.31B | ¥1.58B | ¥1.2B | ¥4.91B |
| Total assets | ¥7.14B | ¥5.78B | ¥5.07B | ¥4B | ¥5.91B |
| Net assets | ¥5.57B | ¥4.25B | ¥3.42B | ¥2.74B | ¥3.57B |
| Share capital | ¥347.8M | ¥119.2M | ¥142.5M | ¥166.4M | ¥979M |
| Property, plant and equipment | ¥6.5M | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangible assets excluding goodwill | ¥149K | ¥149K | ¥0 | ¥0 | ¥0 |
| Investment securities | ¥596.5M | ¥886.2M | ¥357.8M | ¥222.1M | ¥335.8M |
| Current assets | ¥6.3B | ¥4.67B | ¥4.46B | ¥3.62B | ¥5.2B |
| Current liabilities | ¥361.3M | ¥364.1M | ¥486.5M | ¥1.2B | ¥983.8M |
| Bonds | — | — | — | — | ¥1.3B |
| Total liabilities | ¥1.57B | ¥1.53B | ¥1.65B | ¥1.26B | ¥2.34B |
| Non-controlling interests | — | — | — | — | ¥441K |
| Equity attributable to owners of parent | ¥5.58B | ¥4.25B | ¥3.51B | ¥2.73B | ¥3.41B |
| Retained earnings | -¥4.72B | -¥1.37B | -¥2.15B | -¥2.99B | -¥3.93B |
| Treasury stock | -¥27K | -¥27K | -¥27K | -¥27K | -¥27K |
EDINET (FSA Japan)
有価証券報告書－第30期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第29期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第28期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第27期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第26期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第25期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 44
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.